Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003863 · ClinicalTrials.gov registry record
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 391
- Enrollment target
NCT00003863: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00003863 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 391 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003863 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 391 participants
- Enrollment target
Study Summary
RATIONALE: Determination of genetic markers for aggressive non-Hodgkin's lymphoma may help identify patients with this disease and help predict the outcome of treatment. PURPOSE: Diagnostic study to determine the genetic markers in patients who have aggressive non-Hodgkin's lymphoma.
Interventions
- GENETIC cytogenetic analysis
- GENETIC fluorescence in situ hybridization
- GENETIC gene rearrangement analysis
- GENETIC comparative genomic hybridization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 391 participants |
| Start Date | 1999-06 |
| Est. Completion | 2005-05 |
What the finished NCT00003863 record still lists
NCT00003863 is an observational study that tracks outcomes without assigning an intervention. The registered 391 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which cytogenetic analysis is the first listed.
NCT00003863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003863 about?
NCT00003863 is a clinical study titled "Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma". RATIONALE: Determination of genetic markers for aggressive non-Hodgkin's lymphoma may help identify patients with this disease and help predict the outcome of treatment. PURPOSE: Diagnostic study to determine the genetic markers in patients who have aggressive non-Hodgkin's lymphoma.
What is the current status of trial NCT00003863?
This trial is currently completed. The enrollment target is 391 participants. The study started on 1999-06. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00003863?
The interventions under investigation include: cytogenetic analysis (GENETIC), fluorescence in situ hybridization (GENETIC), gene rearrangement analysis (GENETIC), comparative genomic hybridization (GENETIC).
Who is sponsoring clinical trial NCT00003863?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia